妊娠20周起胎儿生长轨迹对低风险人群严重不良围产结局的预测价值:IRIS研究二次分析
该研究为IRIS研究的事后分析,纳入6296例低风险单胎妊娠,评估18+0至23+6周与32+0至36+6周间胎儿生长轨迹对严重不良围产结局(SAPO)的预测价值。结果显示,单独的生长轨迹指标与SAPO风险升高无关,而32+0至36+6周估测胎儿体重(EFW)<第10百分位合并EFW下降>20百分位、以及腹围(AC)或EFW<第10百分位合并AC生长速度(ACGV)<第10百分位与SAPO风险升高相关。作者认为,单独的生长轨迹标准不足以区分胎儿生长受限(FGR)与体质性小胎儿。
要点
- 在低风险单胎妊娠中,单独的AC或EFW下降>20或>50百分位或ACGV<第10百分位与SAPO风险升高无关。
- 32+0至36+6周EFW<第10百分位合并EFW下降>20百分位与SAPO风险升高相关。
- 32+0至36+6周AC或EFW<第10百分位合并ACGV<第10百分位与SAPO风险升高相关,新生儿为小于胎龄儿时关联更强。
核心结论
- 在低风险人群中,单独的胎儿生长轨迹缓慢标准不能充分区分胎儿生长受限与体质性小胎儿。
- 这种缺乏关联可能源于诊断不准确和/或诊断后(如干预和选择)偏倚。
- 作者认为,检测胎盘功能不全的新方法应整合母血清生物标志物和多普勒超声测量等诊断工具的信息。
研究设计与样本
- 本研究为IUGR风险选择(IRIS)研究的事后数据分析,IRIS研究为荷兰全国性整群随机试验,评估常规孕晚期超声筛查降低SAPO的(成本)效果。
- 样本纳入6296例低风险单胎妊娠,其中82例(1.3%)新生儿发生至少一种SAPO。
- 第一次超声检查使用18+0至23+6周常规畸形筛查的超声数据,第二次使用32+0至36+6周进行的超声检查数据。
- 采用多水平逻辑回归分析慢胎儿生长轨迹对SAPO的预测价值,慢生长轨迹定义为AC和/或EFW下降超过20百分位或超过50百分位,或ACGV<第10百分位(p10)。
- 同时分析上述慢生长指标与32+0至36+6周小于胎龄儿(SGA,AC或EFW<p10)及严重SGA(AC/EFW<第3百分位)的组合。
主要发现
- 在6296例低风险单胎妊娠中,82例(1.3%)新生儿发生至少一种SAPO。
- 单独的AC或EFW下降>20或>50百分位或ACGV<p10与SAPO风险升高无关。
- 32+0至36+6周EFW<p10合并EFW下降>20百分位与SAPO发生率升高相关。
- 32+0至36+6周AC或EFW<p10合并ACGV<p10也与SAPO风险升高相关。
- 若新生儿出生时为SGA,上述关联的比值比更高。
关键数值与推荐
- 慢胎儿生长轨迹定义为AC和/或EFW下降超过20百分位或超过50百分位,或ACGV<第10百分位(p10)。
- SGA定义为32+0至36+6周AC或EFW<第10百分位。
- 严重SGA定义为32+0至36+6周AC/EFW<第3百分位。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The placental dysfunction underlying fetal growth restriction (FGR) may result in severe adverse perinatal outcome (SAPO) related to fetal hypoxia. Traditionally, the diagnostic criteria for FGR have been based on fetal size, an approach that is inherently flawed because it often results in either over- or underdiagnosis. The anomaly ultrasound scan at 20 weeks' gestation may be an appropriate time at which to set a benchmark for growth potential of the individual fetus. We hypothesized that the fetal growth trajectory from that point onwards may be informative regarding third-trimester placental dysfunction. The aim of this study was to investigate the predictive value for SAPO of a slow fetal growth trajectory between 18 + 0 to 23 + 6 weeks and 32 + 0 to 36 + 6 weeks' gestation in a large, low-risk population. METHODS: This was a post-hoc data analysis of the IUGR Risk Selection (IRIS) study, a Dutch nationwide cluster-randomized trial assessing the (cost-)effectiveness of routine third-trimester sonography in reducing SAPO. In the current analysis, for the first ultrasound examination we used ultrasound data from the routine anomaly scan at 18 + 0 to 23 + 6 weeks' gestation, and for the second we used data from an ultrasound examination performed between 32 + 0 and 36 + 6 weeks' gestation. Using multilevel logistic regression, we analyzed whether SAPO was predicted by a slow fetal growth trajectory, which was defined as a decline in abdominal circumference (AC) and/or estimated fetal weight (EFW) of more than 20 percentiles or more than 50 percentiles or as an AC growth velocity (ACGV) < 10th percentile (p10). In addition, we analyzed the combination of these indicators of slow fetal growth with small-for-gestational age (SGA) (AC or EFW < p10) and severe SGA (AC/EFW < 3rd percentile) at 32 + 0 to 36 + 6 weeks' gestation. RESULTS: Our sample included the data of 6296 low-risk singleton pregnancies, among which 82 (1.3%) newborns experienced at least one SAPO. Standalone declines in AC or EFW of > 20 or > 50 percentiles or ACGV < p10 were not associated with increased odds of SAPO. EFW < p10 between 32 + 0 and 36 + 6 weeks' gestation combined with a decline in EFW of > 20 percentiles was associated with an increased rate of SAPO. The combination of AC or EFW < p10 between 32 + 0 and 36 + 6 weeks' gestation with ACGV < p10 was also associated with increased odds of SAPO. The odds ratios of these associations were higher if the neonate was SGA at birth. CONCLUSIONS: In a low-risk population, a slow fetal growth trajectory as a standalone criterion does not distinguish adequately between fetuses with FGR and those that are constitutionally small. This absence of association may be a result of diagnostic inaccuracies and/or post-diagnostic (e.g. intervention and selection) biases. We conclude that new approaches to detect placental insufficiency should integrate information from diagnostic tools such as maternal serum biomarkers and Doppler ultrasound measurements. © 2023 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Kamphof HD, van Roekel M, Henrichs J, et al. Predictive value of fetal growth trajectory from 20 weeks of gestation onwards for severe adverse perinatal outcome in low-risk population: secondary analysis of IRIS study. Ultrasound Obstet Gynecol. 2023. PMID: 37204332. doi:10.1002/uog.26250
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。